Skip to main content
Clinical Trials/NCT01731015
NCT01731015
Completed
Phase 1

A Pilot Study for Evaluation of Regional Lung Function in Normal Subjects and Subjects With Airway and Lung Disorders Using 1H Magnetic Resonance Imaging With Oxygen as a Contrast Agent

Hal C Charles1 site in 1 country15 target enrollmentJanuary 2012

Overview

Phase
Phase 1
Intervention
Medical Grade Oxygen
Conditions
COPD
Sponsor
Hal C Charles
Enrollment
15
Locations
1
Primary Endpoint
Image Quality
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The goal of this study is to perform a pilot study to evaluate the utilization of oxygen as an inhaled contrast agent to image the airway spaces in normal and diseased human lungs to allow an effect size estimate to power future studies.

Detailed Description

This is an open label study expanding on work by other groups in animals, ex-vivo human lungs and human subjects. Both 2-dimensional and 3-dimensional images will be obtained using 1H MRI comparing images obtained while breathing oxygen to those obtained breathing room air. Objectives * To determine if 1H magnetic resonance images of the human lung and airways can be obtained in both single breath-hold and gated breathing imaging studies with adequate signal level and image contrast to extract regional lung functional information with oxygen as a contrast agent. * To determine the short term reproducibility of the lung functional imaging in a subset of subjects (5 control subjects and 5 subjects with lung disease) with repeat MRI studies (Visit 2) at a time point ≥ 1 week to ≤ 4 weeks from Visit 1

Registry
clinicaltrials.gov
Start Date
January 2012
End Date
September 2012
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Hal C Charles
Responsible Party
Sponsor Investigator
Principal Investigator

Hal C Charles

Associate Professor Department of Radiology

Duke University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

Normal Subject

Each subject will receive oxygen as a contrast agent to visualize the airway and alveolar spaces in their lungs using magnetic resonance imaging of inert gas/oxygen mixtures. The subjects will receive the gas by breathing room air interleaved with oxygen using a standard Douglas Bag system. No additional drug products, investigational or otherwise will be provided in this study.

Intervention: Medical Grade Oxygen

Subjects with Lung/or Airway Disease

Each subject will receive oxygen as a contrast agent to visualize the airway and alveolar spaces in their lungs using magnetic resonance imaging of inert gas/oxygen mixtures. The subjects will receive the gas by breathing room air interleaved with oxygen using a standard Douglas Bag system. No additional drug products, investigational or otherwise will be provided in this study.

Intervention: Medical Grade Oxygen

Outcomes

Primary Outcomes

Image Quality

Time Frame: one exposure

Assessment of image quality of oxygen enhanced MR images: Signal to Noise Ratio, Dynamic Range of Ratio/Difference Images

Study Sites (1)

Loading locations...

Similar Trials